West Pharmaceutical Services, Inc. (WST)
NYSE: WST · IEX Real-Time Price · USD
331.41
+2.29 (0.70%)
May 31, 2024, 4:00 PM EDT - Market closed

WST Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 1994
Net Income
593.4585.9661.8346.2241.7
Upgrade
Depreciation & Amortization
137.3120.6122.3109.1103.4
Upgrade
Share-Based Compensation
23.323.737.53424.4
Upgrade
Other Operating Activities
22.5-6.2-237.6-16.8-2.3
Upgrade
Operating Cash Flow
776.5724584472.5367.2
Upgrade
Operating Cash Flow Growth
7.25%23.97%23.60%28.68%27.23%
Upgrade
Capital Expenditures
-362-284.6-253.4-174.4-126.4
Upgrade
Acquisitions
00-2.20-104
Upgrade
Other Investing Activities
-6.7-3.62.5-5.12.4
Upgrade
Investing Cash Flow
-368.7-288.2-253.1-179.5-228
Upgrade
Dividends Paid
-57-54.1-51.1-48.1-45.1
Upgrade
Share Issuance / Repurchase
-407.3-201.3-122.5-93.1-58
Upgrade
Debt Issued / Paid
-2.3-45.5-2.2-2.360.9
Upgrade
Other Financing Activities
77.37.76.45.4
Upgrade
Financing Cash Flow
-459.6-293.6-168.1-137.1-36.8
Upgrade
Exchange Rate Effect
11.4-10.5-15.720.5-0.7
Upgrade
Net Cash Flow
-40.4131.7147.1176.4101.7
Upgrade
Free Cash Flow
414.5439.4330.6298.1240.8
Upgrade
Free Cash Flow Growth
-5.67%32.91%10.90%23.80%30.94%
Upgrade
Free Cash Flow Margin
14.05%15.22%11.68%13.89%13.09%
Upgrade
Free Cash Flow Per Share
5.585.914.444.033.25
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).